Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Dermatologic 1CNS 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 26Lung Neoplasms 23Neoplasms 7Small Cell Lung Carcinoma 5Neoplasm Metastasis 4Mesothelioma 4Breast Neoplasms 4Vomiting 3Nausea 3Triple Negative Breast Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Kidney Neoplasms 2Head and Neck Neoplasms 2Brain Neoplasms 2Stomach Neoplasms 1Radiation Pneumonitis 1Postoperative Complications 1Pain, Postoperative 1Nasopharyngeal Neoplasms 1Multiple Myeloma 1Mesothelioma, Malignant 1Melanoma 1Malnutrition 1Lymphoma 1Lung Diseases, Interstitial 1Liver Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1

Interventions

Metformin 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Diabetes Mellitus × Dexamethasone × Thoracic × Clear all
NCT04001725 2019-11-13

OPTIMAL

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown
110 enrolled
BreastCNSDermatologicThoracic

Brain Neoplasms, Breast Neoplasms, Diabetes Mellitus, Lung Neoplasms, Melanoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡